UnknownNot Applicable

Volatiles in Breath and Headspace Analysis - Diagnostic Markers

Latvia3,000 participantsStarted 2017-07-24

Plain-language summary

Detection of Volatile Organic Compounds (VOC) directly from tissue by headspace analysis (skin, surgery material, other tissue) and exhaled breath is feasible using affordable user-friendly novel nano-chemo sensors that can accurately be used for screening and monitoring purpose

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Informed Consent signed * Individual with targeted disease/lesion (tuberculosis, gastric cancer, gastric dysplasia, high/ normal/ low risk gastric lesions, colorectal cancer, high-risk colorectal lesions, low-risk colorectal adenoma, pancreatic cancer, chronic pancreatitis, liver cancer, chronic liver disease, other infectious diseases, oncological diseases of other location) Exclusion Criteria: * Informed Consent not signed * Other active cancer at the time of inclusion for particular study group

What they're measuring

Specific VOC detected

Timeframe: 2 years

Performance of nanoarray sensor testing to detect target lesions and diseases

Timeframe: At the time of breath sampling

Trial details

NCT IDNCT03228095

SponsorUniversity of Latvia

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-12-20

View on ClinicalTrials.gov More Tuberculosis trials